1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Metabolismo de lípidos

Metabolismo de lípidos

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Ronald J, Rajagopalan R, Cerrato F, Nord AS, Hatsukami T, Kohler T, Marcovina S, Heagerty P, Jarvik GP.

    Genetic Variation in LPAL2, LPA, and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk

    Stroke . 42(1): 2-9. Nº de citas: 30

    [doi:10.1161/STROKEAHA.110.591230]

  • Rodríguez-Acebes S, Palacios N, Botella-Carretero JI, Olea N, Crespo L, Peromingo R, Gómez-Coronado D, Lasunción MA, Vázquez C, Martínez-Botas J.

    Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: Distinct expression of cell-cycle- and differentiation-related genes

    BMC MEDICAL GENOMICS . 3: 61-61. Nº de citas: 35

    [doi:10.1186/1755-8794-3-61]

  • Guardiola M, Ribalta J, Gómez-Coronado D, Lasunción MA, de Oya M, Garcés C.

    The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study)

    Atherosclerosis . 212(2): 543-547. Nº de citas: 17

    [doi:10.1016/j.atherosclerosis.2010.07.004]

  • Albillos A, Nieto M, Ubeda M, Muñoz L, Fraile B, Reyes E, Lledó L, Blanco I, Pastor O, Salas C, Lario M, Monserrat J, Bataller R, Alvarez-Mon M.

    The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis

    Gut . 59(7): 943-952. Nº de citas: 9

    [doi:10.1136/gut.2008.168831]

  • Sánchez-Wandelmer J, Dávalos A, de la Peña G, Cano S, Giera M, Canfrán-Duque A, Bracher F, Martín-Hidalgo A, Fernández-Hernando C, Lasunción MA, Busto R.

    HALOPERIDOL DISRUPTS LIPID RAFTS AND IMPAIRS INSULIN SIGNALING IN SH-SY5Y CELLS

    Neuroscience . 167(1): 143-153. Nº de citas: 38

    [doi:10.1016/j.neuroscience.2010.01.051]

  • Cuevas EP, Escribano O, Monserrat J, Martínez-Botas J, Sánchez MG, Chiloeches A, Hernández-Breijo B, Sánchez-Alonso V, Román ID, Fernández-Moreno MD, Guijarro LG.

    RNAi-Mediated Silencing of Insulin Receptor Substrate-4 Enhances Actinomycin D- and Tumor Necrosis Factor-alpha-Induced Cell Death in Hepatocarcinoma Cancer Cell Lines

    JOURNAL OF CELLULAR BIOCHEMISTRY . 108(6): 1292-1301. Nº de citas: 19

    [doi:10.1002/jcb.22359]

  • Mütze U, Gleich F, Garbade SF, Plisson C, Aldámiz-Echevarría L, Arrieta F, Ballhausen D, Zielonka M, Petkovic Ramadža D, Baumgartner MR, Cano A, García Jiménez MC, Dionisi-Vici C, Ješina P, Blom HJ, Couce ML, Meavilla Olivas S, Mention K, Mochel F, Morris AAM, Mundy H, Redonnet-Vernhet I, Santra S, Schiff M, Servais A, Vitoria I, Huemer M, Kožich V, Kölker S.

    Postauthorization safety study of betaine anhydrous.

    Journal of inherited metabolic disease . : .

    [doi:10.1002/jimd.12499]

  • Mora-Rodríguez JM, Sánchez BG, Bort A, Díaz-Yuste A, Ballester-González R, Arrieta F, Sebastián-Martín A, Díaz-Laviada I.

    Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM).

    LIFE SCIENCES . 336: 122292-122292.

    [doi:10.1016/j.lfs.2023.122292]

  • Rodríguez-Otero N, Fernández-Lozano C, Vicente-Santamaría S, Díaz-Montalvo L, Menéndez-Conde C, Sola-Martínez FJ.

    Rapid drug desensitization protocol in delayed hypersensitivity reactions to CFTR modulator drugs: When everyday counts.

    Journal of investigational allergology & clinical immunology . : .

    [doi:10.18176/jiaci.0982]